You have free access to this content

American Journal of Transplantation

Cover image for Vol. 13 Issue 1

January 2013

Volume 13, Issue 1

Pages 1–241

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 1–2)

      Article first published online: 26 DEC 2012 | DOI: 10.1111/ajt.12071

      Due to privacy restrictions, the SRTR no longer has access to Social Security death data. We take a look at what this means for transplantation research and patient care, and at possible solutions. Also this month, we recount some of the papers written by 2012 Nobel laureate Alvin E. Roth published in the pages of AJT.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      LITERATURE Watch: Implications for transplantation (page 3)

      Leonardo Riella and Jonathan S. Bromberg

      Article first published online: 26 DEC 2012 | DOI: 10.1111/ajt.12072

      • image

      One of the greatest challenges of modern science is integrating all of the knowledge derived from the identification of innumerable genes, molecules, and cells for the improvement of health; three recent papers suggest the growing field of systems biology might help translate these discoveries into tangible clinical benefits.

  3. Special Feature

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Dr. Joseph E. Murray (1919–2012): A Life of Curiosity, Humanism, and Persistence (pages 5–6)

      S. G. Tullius

      Article first published online: 26 DEC 2012 | DOI: 10.1111/ajt.12076

      • image

      This special tribute commemorates the father of clinical organ transplantation.

  4. Editorials

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Balancing Accountable Care With Risk Aversion: Transplantation as a Model (pages 7–8)

      D. A. Axelrod

      Article first published online: 26 DEC 2012 | DOI: 10.1111/j.1600-6143.2012.04346.x

      Transplantation is widely regarded as a model of accountability and transparency in healthcare; however, failure to accurately measure and report appropriate performance metrics is likely to result in risk aversion and decreased access to transplant for higher risk populations. See also Schold et al (page 67) and Schnier et al (page 31).

    2. You have free access to this content
      The Cam-Path Forward (pages 9–10)

      A. D. Kirk

      Article first published online: 21 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04324.x

      The author discusses the drug alemtuzumab as a case study in the benefits and drawbacks of off-label drug use in organ transplantation. See article by van den Hoogen et al on page 192.

  5. Minireviews

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      MicroRNAs as Biomarkers in Solid Organ Transplantation (pages 11–19)

      V. R. Mas, C. I. Dumur, M. J. Scian, R. C. Gehrau and D. G. Maluf

      Article first published online: 8 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04313.x

      • image
      • image
      • image

      The authors summarize recent reports detailing the identification, mechanism, clinical application and limitations of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction.

    2. You have free access to this content
      Disruptions in the Supply of Medications Used in Transplantation: Implications and Management Strategies for the Transplant Clinician (pages 20–30)

      J. C. Krisl, C. R. Fortier and D. J. Taber

      Article first published online: 5 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04308.x

      • image
      • image

      This review discusses the incidence and impact of drug shortages in solid organ transplantation and provides recommendations for transplant clinicians on appropriate therapeutic and global management of these shortages.

  6. Personal Viewpoint

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Transplantation at the Nexus of Behavioral Economics and Health Care Delivery (pages 31–35)

      K. E. Schnier, J. C. Cox, C. McIntyre, R. Ruhil, V. Sadiraj and N. Turgeon

      Article first published online: 26 DEC 2012 | DOI: 10.1111/j.1600-6143.2012.04343.x

      This viewpoint discusses behavioral economic principles and how they might be applied to transplantation using a synergistic collaboration between transplant physicians and economists. See also editorial by Axelrod on page 7 and article by Schold et al on page 67.

  7. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. Basic Science

      You have free access to this content
      Leptin Modulates Allograft Survival by Favoring a Th2 and a Regulatory Immune Profile (pages 36–44)

      P. M. M. Moraes-Vieira, E. J. Bassi, R. A. Larocca, A. Castoldi, M. Burghos, A. P. Lepique, F. J. Quintana, R. C. Araujo, A. S. Basso, T. B. Strom and N. O. S. Câmara

      Article first published online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04283.x

      • image
      • image
      • image
      • image

      The authors suggest a possible explanation for the increased susceptibility of hyperleptinemic obese patients to acute and chronic graft rejection.

      Corrected by:

      Errata: Erratum

      Vol. 13, Issue 8, 2231, Article first published online: 26 JUL 2013

    2. You have free access to this content
      Cord Blood T Cells Retain Early Differentiation Phenotype Suitable for Immunotherapy After TCR Gene Transfer to Confer EBV Specificity (pages 45–55)

      G. Frumento, Y. Zheng, G. Aubert, M. Raeiszadeh, P. M. Lansdorp, P. Moss, S. P. Lee and F. E. Chen

      Article first published online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04286.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Human umbilical cord blood T cells can be redirected by T cell receptor gene transduction to target Epstein–Barr virus epitopes, and when compared in vitro with adult T cells they demonstrate properties predictive of better in vivo proliferative capacity and effector function, suggesting that cord blood can be used as a third party source of T cells for immunotherapy of posttransplant lymphoproliferative disease.

    3. You have free access to this content
      Targeting TIM-1 on CD4 T Cells Depresses Macrophage Activation and Overcomes Ischemia-Reperfusion Injury in Mouse Orthotopic Liver Transplantation (pages 56–66)

      Y. Zhang, H. Ji, X. Shen, J. Cai, F. Gao, K. M. Koenig, C. M. Batikian, R. W. Busuttil and J. W. Kupiec-Weglinski

      Article first published online: 8 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04316.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      A subpopulation of activated CD4 T cells expressing the TIM-1 receptor is required to trigger hepatic damage in mouse liver transplants subjected to prolonged periods of cold storage.

    4. Clinical Science

      You have free access to this content
      The Association of Center Performance Evaluations and Kidney Transplant Volume in the United States (pages 67–75)

      J. D. Schold, L. D. Buccini, T. R. Srinivas, R. T. Srinivas, E. D. Poggio, S. M. Flechner, C. Soria, D. L. Segev, J. Fung and D. A. Goldfarb

      Article first published online: 26 DEC 2012 | DOI: 10.1111/j.1600-6143.2012.04345.x

      • image
      • image
      • image
      • image

      There is a significant association between low performance evaluations of transplant centers in programspecific reports and a decline in kidney transplant volume. See also editorial by Axelrod on page 7 and personal viewpoint by Schnier et al on page 31.

    5. You have free access to this content
      Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch (pages 76–85)

      A. Bentall, L. D. Cornell, J. M. Gloor, W. D. Park, M. J. Gandhi, J. L. Winters, M. F. Chedid, P. G. Dean and M. D. Stegall

      Article first published online: 16 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04291.x

      • image
      • image
      • image
      • image

      This study demonstrates that patients with anti-class II donor-specific antibodies at baseline in positive crossmatch kidney transplants have increased early transplant glomerulopathy at one year and higher rates of graft loss compared to anti-class I antibodies alone.

    6. You have free access to this content
      Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure (pages 86–99)

      M. Naesens, D. R. J. Kuypers, K. De Vusser, Y. Vanrenterghem, P. Evenepoel, K. Claes, B. Bammens, B. Meijers and E. Lerut

      Article first published online: 8 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04304.x

      • image
      • image
      • image
      • image
      • image

      In this single-center study, the authors demonstrate that early chronic histological damage in renal allograft indication biopsies is an independent risk factor for late graft loss, irrespective of whether a specific, progressive disease is present.

    7. You have free access to this content
      Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation (pages 100–110)

      T. Isakova, H. Xie, S. Messinger, F. Cortazar, J. J. Scialla, G. Guerra, G. Contreras, D. Roth, G. W. Burke III, M. Z. Molnar, I. Mucsi and M. Wolf

      Article first published online: 1 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04281.x

      • image
      • image

      The authors conduct an observational study of 139,370 recipients who underwent kidney transplantation between 1999 and 2010 in the United States and find that compared with calcineurin-inhibitor-based regimens, use of mammalian target of rapamycin–based regimens for primary immunosuppression is associated with inferior recipient survivals.

    8. You have free access to this content
      Medical Outcomes in African American Live Kidney Donors: A Matched Cohort Study (pages 111–118)

      M. D. Doshi, M. O. Goggins, L. Li and A. X. Garg

      Article first published online: 24 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04303.x

      • image
      • image

      Live kidney donation is associated with increased incidence of hypertension in African Americans.

    9. You have free access to this content
      A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22-Year Prospective Study in an Ethnically Diverse Population (pages 119–129)

      C. A. Harwood, D. Mesher, J. M. McGregor, L. Mitchell, M. Leedham-Green, M. Raftery, R. Cerio, I. M. Leigh, P. Sasieni and C. M. Proby

      Article first published online: 16 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04292.x

      • image
      • image
      • image
      • image

      The authors employ an evidence-based approach to skin cancer surveillance in renal transplant recipients in a singlecentre prospective study.

    10. You have free access to this content
      Value of Routine Voiding Cystourethrography After Renal Transplantation (pages 130–135)

      M. Margreiter, G. P. Györi, G. A. Böhmig, S. Trubel, F. Mühlbacher and R. Steininger

      Article first published online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04284.x

      • image
      • image
      • image

      By examining the value of routine voiding cystourethrography in a large cohort of kidney transplant patients, the authors show that the early vesicoureteral reflux has no meaningful effect on death-censored graft survival or overall patient survival.

    11. You have full text access to this OnlineOpen article
      Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study (pages 136–145)

      H. H. Hirsch, F. Vincenti, S. Friman, M. Tuncer, F. Citterio, A. Wiecek, E. H. Scheuermann, M. Klinger, G. Russ, M. D. Pescovitz and H. Prestele

      Article first published online: 8 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04320.x

      • image
      • image
      • image

      In a study of kidney transplant recipients randomized 1:1 to receive either cyclosporine-A or tacrolimus together with a common backbone of basiliximab induction, mycophenolate and steroids, higher steroid exposure, tacrolimus, male gender and older age are identified as independent risk factors for BK virus in the first year posttransplant. See a related manuscript by Theodoropoulos et al on page 197.

    12. You have free access to this content
      High-Quality CMV-Specific CD4+ Memory Is Enriched in the Lung Allograft and Is Associated With Mucosal Viral Control (pages 146–156)

      J. A. Akulian, M. R. Pipeling, E. R. John, J. B. Orens, N. Lechtzin and J. F. McDyer

      Article first published online: 27 SEP 2012 | DOI: 10.1111/j.1600-6143.2012.04282.x

      • image
      • image
      • image
      • image
      • image

      This study shows that cytomegalovirus-specific CD4+ memory T cells are enriched in the lung allograft, multifunctional, and associated with mucosal viral control in lung transplant recipients.

    13. You have free access to this content
      Functional Status After Lung Transplantation in Older Adults in the Post-Allocation Score Era (pages 157–166)

      L. Genao, H. E. Whitson, D. Zaas, L. L. Sanders and K. E. Schmader

      Article first published online: 21 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04299.x

      • image
      • image
      • image
      • image
      • image
      • image

      Lung transplantation has a positive effect on the functional status trajectories of both older (age 65 and higher) and younger (age 18–64) recipients, who rarely reach significant disability at 48 months posttransplantation.

    14. You have free access to this content
      Transmission of Angiosarcomas From a Common Multiorgan Donor to Four Transplant Recipients (pages 167–173)

      J. Thoning, Y. Liu, C. Bistrup, A. Thomassen, C. Borst, N. Marcussen and M. Tepel

      Article first published online: 24 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04301.x

      • image
      • image
      • image

      The authors describe an association of urokinase-plasminogen-activator-receptor in donor tumor transmission of metastatic angiosarcomas to four transplant recipients who received organs from an apparently unaffected, common, deceased multiorgan donor.

    15. You have free access to this content
      Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients (pages 174–183)

      R. Na, A. E. Grulich, N. S. Meagher, G. W. McCaughan, A. M. Keogh and C. M. Vajdic

      Article first published online: 24 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04302.x

      • image
      • image

      Cancer incidence is increased in Australian pediatric and adult liver and cardiothoracic transplant recipients, and the risk of cancer is higher in heart and lung recipients as compared to liver transplant recipients.

    16. You have free access to this content
      Liver Transplantation Outcome in Patients With Angiographically Proven Coronary Artery Disease: A Multi-Institutional Study (pages 184–191)

      C. Wray, J. C. Scovotti, J. Tobis, C. U. Niemann, R. Planinsic, A. Walia, J. Findlay, G. Wagener, J. B. Cywinski, D. Markovic, C. Hughes, A. Humar, A. Olmos, R. Sierra, R. Busuttil and R. H. Steadman

      Article first published online: 5 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04293.x

      • image
      • image

      The authors find no significant difference in post-liver transplant survival between patients with and without angiographically proven obstructive coronary artery disease when current treatment regimens are employed.

  8. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Treatment of Steroid-Resistant Acute Renal Allograft Rejection With Alemtuzumab (pages 192–196)

      M. W. F. van den Hoogen, D. A. Hesselink, W. J. van Son, W. Weimar and L. B. Hilbrands

      Article first published online: 21 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04328.x

      The authors show that alemtuzumab might be equally effective and as safe as antithymocyte globulin for the treatment of steroid-resistant renal allograft rejections, but with a significantly lower incidence of infusion-related side effects, the possibility to administer alemtuzumab subcutaneously, and lower costs. See editorial by Kirk on page 9.

    2. You have free access to this content
      BK Virus Replication and Nephropathy After Alemtuzumab-Induced Kidney Transplantation (pages 197–206)

      N. Theodoropoulos, E. Wang, S. Penugonda, D. P. Ladner, V. Stosor, J. Leventhal, J. Friedewald, M. P. Angarone and M. G. Ison

      Article first published online: 8 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04314.x

      • image
      • image
      • image
      • image
      • image

      This retrospective cohort study of 666 kidney transplant recipients shows that the incidence of BK viruria, viremia and nephropathy is not significantly different among kidney transplant recipients who receive alemtuzumab induction when compared to patients who receive less potent induction. See article by Hirsch et al on page 136.

    3. You have free access to this content
      Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients (pages 207–213)

      C. Lebbe, R. Porcher, A. G. Marcelin, F. Agbalika, E. Dussaix, D. Samuel, S. Varnous, S. Euvrard, A. Bigorie, H. Creusvaux, C. Legendre, C. Frances and the Skin and Organ Transplantation Group of the French Society of Dermatology

      Article first published online: 11 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04290.x

      • image
      • image

      This prospective French national cohort study shows a cumulative incidence of 28% of human herpesvirus-8 seroconversion among organ transplant recipients at risk of contamination, without any difference regardless of the organ transplanted, together with an overall very low prevalence of positive viremia and morbidity.

    4. You have free access to this content
      Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study (pages 214–221)

      G. Tessari, L. Naldi, L. Boschiero, E. Minetti, S. Sandrini, F. Nacchia, F. Valerio, C. Rugiu, F. Sassi, E. Gotti, L. Fonte, G. Talamini and G. Girolomoni

      Article first published online: 11 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04294.x

      • image

      Renal transplant recipients are at high risk of primary and second cancers, including unusual cancers, but cancer-related mortality is not substantially increased if compared to an age- and sex-matched reference population.

    5. You have free access to this content
      A Novel Organ Preservation for Small Partial Liver Transplantations in Rats: Venous Systemic Oxygen Persufflation With Nitric Oxide Gas (pages 222–228)

      S. Yagi, K. Nagai, P. Kadaba, M. Afify, S. Teramukai, S. Uemoto and R. H. Tolba

      Article first published online: 5 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04310.x

      • image
      • image
      • image
      • image

      The authors report that venous systemic oxygen persufflation with nitric oxide gas is a novel, effective method for small partial liver transplantation in rats that alleviates liver graft injury and improves regeneration.

  9. Case Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Triple Red Blood Cell Alloantibody Formation After Bone-Allograft Transplantation (pages 229–231)

      L. Prinzen, H. M. Staal, S. J. M. Rouwette, E. A. M. Beckers, R. H. M. ten Broeke, L. W. van Rhijn and Y. M. C. Henskens

      Article first published online: 24 OCT 2012 | DOI: 10.1111/j.1600-6143.2012.04300.x

      A 13-year-old boy with no history of blood transfusions developed three different rhesus alloantibodies after receiving a bone allograft, providing evidence that primary red blood cell immunization is possible after bone allograft transplantation.

  10. Reports From the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (pages 232–235)

      Article first published online: 26 DEC 2012 | DOI: 10.1111/ajt.12073

      This document details the new recommendation for utilizing the 13-valent pneumococcal conjugate vaccine in place of the 23-valent polysaccharide vaccine in transplant recipients and the majority of candidates.

  11. Images in Transplantation

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. CME

      You have free access to this content
      Fever and Rash One Month After Orthotopic Liver Transplantation (pages 236–238)

      M. Hobeika, R. Pollitt, C. Freise and K. Shinkai

      Article first published online: 26 DEC 2012 | DOI: 10.1111/j.1600-6143.2012.04309.x

      • image
      • image
      • image
  12. Letter to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Reducing Early Exposure to Calcineurin Inhibitors: The Key Factor for a Successful Renal Sparing Strategy (page 239)

      M. Rodríguez-Perálvarez , G. Germani , T. Darius , J. Lerut , E. Tsochatzis  and A. K. Burroughs 

      Article first published online: 5 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04306.x

    2. You have free access to this content
  13. Erratum

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Special Feature
    5. Editorials
    6. Minireviews
    7. Personal Viewpoint
    8. Original Articles
    9. Brief Communications
    10. Case Report
    11. Reports From the CDC: MMWR
    12. Images in Transplantation
    13. Letter to the Editor
    14. Erratum
    1. You have free access to this content
      Erratum (page 241)

      Article first published online: 26 DEC 2012 | DOI: 10.1111/ajt.12074

      This article corrects:

      Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

      Vol. 11, Issue 11, 2405–2413, Article first published online: 22 SEP 2011

SEARCH

SEARCH BY CITATION